Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-(3-aminopropoxy)-2,6-bis(1-methylethyl)phenyl ester (9CI)

Request For Quotation
Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-(3-aminopropoxy)-2,6-bis(1-methylethyl)phenyl ester (9CI) Basic information
Product Name:Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-(3-aminopropoxy)-2,6-bis(1-methylethyl)phenyl ester (9CI)
Synonyms:Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-(3-aminopropoxy)-2,6-bis(1-methylethyl)phenyl ester (9CI);ACAT-IN-4
CAS:454203-56-6
MF:C32H50N2O5S
MW:574.81
EINECS:
Product Categories:
Mol File:454203-56-6.mol
Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-(3-aminopropoxy)-2,6-bis(1-methylethyl)phenyl ester (9CI) Structure
Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-(3-aminopropoxy)-2,6-bis(1-methylethyl)phenyl ester (9CI) Chemical Properties
density 1.087±0.06 g/cm3(Predicted)
pka2.18±0.70(Predicted)
Safety Information
MSDS Information
Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-(3-aminopropoxy)-2,6-bis(1-methylethyl)phenyl ester (9CI) Usage And Synthesis
UsesACAT-IN-4 (Example 208) is an acyl-Coenzyme A:cholesterol acyltransferase (ACAT) inhibitor. ACAT-IN-4 inhibits NF-κB mediated transcription[1].
References[1] Joseph Anthony Cornicelli, et al. Sulfonylaminocarbonyl derivatives for the treatment of nuclear factor-kappa B mediated diseases and disorders. EP1236468A1.
Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-(3-aminopropoxy)-2,6-bis(1-methylethyl)phenyl ester (9CI) Preparation Products And Raw materials
Tag:Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-(3-aminopropoxy)-2,6-bis(1-methylethyl)phenyl ester (9CI)(454203-56-6) Related Product Information
Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-(3-aminopropoxy)-2,6-bis(1-methylethyl)phenyl ester (9CI) Avasimibe Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-amino-2,6-bis(1-methylethyl)phenyl ester (9CI) Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-amino-2,6-dimethoxyphenyl ester (9CI) Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-[[(aminoacetyl)amino]methyl]-2,6-bis(1-methylethyl)phenyl ester (9CI) Sulfamic acid, N-[2-[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 4-(3-aminopropoxy)-2,6-bis(1-methylethyl)phenyl ester, hydrochloride (1:1)